Fig. 1From: Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patientsCD3+CD8+T cells in PBMCs. a Percentage of total CD8+ cells, b percentage of CD8+PD-1+ cells, c percentage of CD8+CD73+ cells and d percentage of CD8+PD-1+CD73+ cells in melanoma patients versus healthy subjects (controls n = 20, melanoma n = 100). Statistical analysis was performed with Mann–Whitney test. Line indicates the medianBack to article page